Breaking News, Collaborations & Alliances

AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.   For the past several months, AMRI has been providing development, scale-up and manufacturing services at a number of its global R&D and production sites, demonstrating operational flexibility and expert...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters